Article
Breast cancer genomics and immuno-oncological markers to guide immune therapies
6 Nov 2017
Abstract excerpt
There is an increasing awareness of the importance of tumor - immune cell interactions to the evolution and therapy responses of breast cancer (BC). Not surprisingly, numerous studies are currently assessing the clinical value of immune modulation for BC patients. However, till now durable clinical responses are only rarely observed. It is important to realize that BC is a heterogeneous disease comprising several...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
